Skip to content
Stop using now Drug recall · FDA · Published February 14, 2018

Bella All Natural Recalls Bella Capsules Due to Undeclared Sibutramine

Bella All Natural recalls 32 bottles of Bella Capsules 600mg due to undeclared sibutramine. Check your lot number and expiration date for details.

🇺🇸 FDA recall #D-0593-2018DrugBella All Natural ›
Take action

Contact the company

Recalling firmBella All Natural304 E 11th St · Los Angeles, CA 90015-1715
✎ GovInfoNow plain-language explainer

What happened, in plain English

Bella All Natural is recalling 32 bottles of its Bella Capsules, 600mg, 30-count bottles because they contain undeclared sibutramine. Sibutramine was withdrawn from the U.S. market in October 2010 due to safety concerns, meaning this product's safety and efficacy have not been established. The recall covers products distributed in California to online customers and retail stores. Read more at govinfonow.com/recall/40812-bella-all-natural-recalls-bella-capsules-due-to-undeclared-sibutramine.

Source Summary by GovInfoNow · govinfonow.com/recall/40812-bella-all-natural-recalls-bella-capsules-due-to-undeclared-sibutramine · Updated October 11, 2026 · FDA enforcement record: FDA #D-0593-2018

Cite this page

“Bella All Natural Recalls Bella Capsules Due to Undeclared Sibutramine.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/40812-bella-all-natural-recalls-bella-capsules-due-to-undeclared-sibutramine. Based on FDA recall #D-0593-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0593-2018%22&limit=1).

Why it’s dangerous

The product contains sibutramine, a controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns. Because the presence of this undeclared ingredient renders the product an unapproved drug, its safety and efficacy have not been established for consumers.

Who’s affected

Consumers who purchased Bella Capsules from online retailers or retail stores in California are likely affected. Individuals taking this supplement for weight loss or other purposes are at risk of exposure to an unapproved drug ingredient.

How to tell if you have this one

Look for 30-count bottles of Bella Capsules, 600mg, manufactured by Bella All Natural at 304 E 11th Street, Los Angeles, CA 90015. Check the lot number for MFD:10.15.2017 and an expiration date of Exp.10/14/2019.

  • Brand
    Bella All Natural
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not consume the recalled Bella Capsules due to the presence of undeclared sibutramine.

  2. Discard or return the item

    The record does not specify a specific remedy such as a refund or replacement, so consumers should dispose of the product safely.

Where it went and when

Where it was distributed

Distributed in California.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Product was distributed in California to online customers and retail stores.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: California.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Feb 14, 201812. FDA classified it Class I: Mar 13, 201823. Published in FDA’s Enforcement Report: Mar 14, 201834. FDA terminated the recall: Jan 28, 2019420182019
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0593-2018 (February 14, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0593-2018 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA